PET tracer identifies bacterial infections
The new imaging agent offers a non-invasive method of detecting infection and monitoring antibiotic therapy...
List view / Grid view
The new imaging agent offers a non-invasive method of detecting infection and monitoring antibiotic therapy...
Imaging agents developed to better monitor the growth of tumours and generate new therapies...
Researchers have discovered that impairing a critical partnership between brain cells can lead to neurodegeneration...
NPL's new approach informed by government priorities, consultancy with industry and the NHS, and a century of expertise, will see it focus on some of the world’s biggest health challenges, from supporting the diagnosis and treatment of cancer and dementia, to reducing attrition rates in drug development, to creating new…
Researchers have tested a new MRI contrast agent that pinpoints breast cancers at early stages and differentiates between aggressive and slow-growing types...
Scientists have used PET imaging to study brain inflammation following Zika virus infection in mice, allowing investigators to study the progression of the disease over time...
Flow cytometry continues to evolve at a fast pace and provides neuroscientists with the ability to perform many highly-specialised assays simultaneously. It meets the demands of cutting-edge research in neuroscience that has allowed researchers to isolate particular neural cells from heterogeneous population and catalogue its molecular or physical features...
Physiologically relevant models to evaluate the effects of drug candidates early in the drug discovery and development process are becoming increasingly important to develop. Various 3D cell/tissue models have emerged offering relevant environment for ex vivo assays, but significant progress is required to streamline and automate the end-to-end workflow. Several…
Researchers have displayed structural details of amyloid structures which may answer many questions on the growth of harmful deposits...
The development of technology that can ‘see’ inside our bodies is one of the great achievements of modern medicine.1 For over 100 years, doctors have used imaging methods for this very reason to help guide patient care. Initially, two-dimensional x-ray pictures of bones and chests were used to help diagnose…
The automated imaging and high-content imaging (HCI) markets are experiencing a widening dichotomy of users’ needs. Diverse hardware and software solutions are needed to bridge this divide...
This In-Depth Focus explores current uses and future development in mass spectrometry imaging for bringing new drugs to market...
Scientists have developed a microscopy method that generates fast and reliable 3D images of curvilinear structures...
Advanced 2D imaging and analysis help scientists rapidly trace anatomical and molecular aspects of diseases to advance drug discovery...
Included in this issue: The importance of industry partnerships; Calcilytics as potential novel therapeutic treatments to halt Alzheimer's disease; Accelerating neuroscience research with flow cytometry...